Cite
Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis.
MLA
Song, Eun Mi, et al. “Comparison of Outcomes of Cyclosporine A and Infliximab for Steroid‐refractory Acute Severe Ulcerative Colitis.” Journal of Gastroenterology & Hepatology, vol. 36, no. 9, Sept. 2021, pp. 2463–70. EBSCOhost, https://doi.org/10.1111/jgh.15508.
APA
Song, E. M., Oh, E. H., Hwang, S. W., Park, S. H., Yang, D., Byeon, J., Myung, S., Yang, S., & Ye, B. D. (2021). Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis. Journal of Gastroenterology & Hepatology, 36(9), 2463–2470. https://doi.org/10.1111/jgh.15508
Chicago
Song, Eun Mi, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, and Byong Duk Ye. 2021. “Comparison of Outcomes of Cyclosporine A and Infliximab for Steroid‐refractory Acute Severe Ulcerative Colitis.” Journal of Gastroenterology & Hepatology 36 (9): 2463–70. doi:10.1111/jgh.15508.